Cartesse

About Rosivo

Rosivo is pioneering a decellularized and stabilized porcine cartilage implant platform to transform reconstructive surgery. The company's technology targets the substantial unmet need in rhinoplasty and facial reconstruction, where current graft options suffer from high long-term failure rates, leading to frequent revision surgeries. By offering a readily available, biocompatible, and mechanically stable product, Rosivo aims to make surgery safer, less invasive, and more predictable. Founded in 2019, the company is in the pre-clinical/development stage, building a team with expertise in biologics engineering and facial plastic surgery.

Therapeutic Areas